Effects of Spinal Cord Stimulation Therapy on Motor Function and Gait in Patients With Pure Hereditary Spastic Paraplegias

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

It's a single-center, prospective, open label clinical study with a 12 months follow-up period, to investigate the therapeutic effect and safety of spinal cord stimulation (SCS) on motor function and gait in patients with pure Hereditary Spastic Paraplegias.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 14
Maximum Age: 70
Healthy Volunteers: No
View:

• aged between 14 and 70 years

• patients with pure hereditary spastic paraplegias

• with progressive weakness and spasticity of the lower limbs, and the gait dysfunction treatable by medication but not adequately controlled with medications

• Understand potential risk/benefit, consent to the study, study procedures, and agree to complete the study follow-up visits and comply with the study protocol requirements.

Locations
Other Locations
China
Xuanwu Hospital,Capital Medical University
Recruiting
Beijing
Contact Information
Primary
Jiping Li, MD
yhljp89@163.com
8610-83198899-8630
Time Frame
Start Date: November 15, 2021
Estimated Completion Date: December 2023
Participants
Target number of participants: 12
Treatments
Experimental: Spinal cord stimulation therapy
Spinal cord stimulation at the thoracic levels ranging from T10 to T12.
Authors
Yuqing Zhang
Sponsors
Leads: Xuanwu Hospital, Beijing

This content was sourced from clinicaltrials.gov

Similar Clinical Trials